Andrew Ng has over 13 years of experience in the healthcare industry across Asia and the U.S. He joined VMS Group in 2017, and has established the Group’s healthcare practice since then. He has led multiple growth-stage investments for the Group across the therapeutics, diagnostics, medical device and CRO/ CDMO verticals. Before that, Andrew was the Head of China Healthcare Research at Barclays Capital. He also served as an investment banker, where he covered healthcare clients across the Asia Pacific region. He started his career as a management consultant at ZS Associate, advising global pharma on sales and marketing strategy and operations. Andrew received an MBA from INSEAD, a M.Eng. degree and a B.S. degree in Operations Research & Engineering from Cornell University.